Message :

Peer-Reviewed Study: Highly Bioavailable Curcumin


Highly bioavailable curcumin from CAVACURMIN® empowers your formulation with unique advantages: 40 times better absorption than pure curcumin products and easy formulation into shots, capsules and tablets. Read the clinical human study on the exceptional bioavailability of CAVACURMIN® – published by the European Journal of Nutrition.

Related Content

Wacker Chemie AG


Wacker Chemie AG

Hanns-Seidel-Platz 4








Tel. +49 89 6279-1346

Fax. +49 89 6279-2507

WACKER BIOSOLUTIONS, WACKER’s life science and biotechnology division, offers a broad range of innovative tailored products and solutions for the life science sector – particularly for the functional food and nutraceutical industries. 

These include CAVAMAX® W6 alpha-cyclodextrin, a natural, starch-derived oligosaccharide. It can be added as a fully fermentable dietary fiber to foods and beverages, including carbonated and non-carbonated transparent soft drinks. CAVAMAX® W6 is scientifically proven to significantly reduce the post-prandial glycaemic response – an effect officially acknowledged by EFSA. Besides, it interacts with triglycerides building up a surfactant-like structure that stabilizes oil-in-water emulsions efficiently. With CAVAMAX® W6, WACKER thus offers manufacturers a possibility to replace emulsifiers with a soluble fiber.

Furthermore, WACKER offers molecular encapsulation solutions based on our cyclodextrin technology for odor or taste-masking, to stabilize food ingredients against heat and oxidation and to increase the bioavailability of functional ingredients. We have over 15 years of experience in manufacturing and formulating alpha-, beta- and gamma-cyclodextrins. 

Additionally, WACKER produces a high-quality range of non-human, non-animal derived L-cysteine products. WACKER is the world’s only manufacturer of vegetarian-grade cysteine using a patented biotech process.

Articles On NutritionInsight
Nutrition & Health News 27 September 2017

Wacker hydroxytyrosol shown to significantly lower LDL cholesterol

27 Sep 2017 --- Wacker has announced the results of a human clinical study demonstrating that their hydroxytyrosol HTEssence is capable of significantly reducing low-density lipoprotein (LDL) cholesterol. At SupplySide West 2017 (September 27-29, Las Vegas), the company is exhibiting its “nature-identical” hydroxytyrosol HTEssence.

Nutrition & Health News 12 May 2017

Turmeric and Curcumin: Standout Trend at Vitafoods 2017

12 May 2017 --- One of the standout trends at Vitafoods 2017 was the rise of products featuring turmeric and its derivative, curcumin. “The market for turmeric is blooming,” Alexis Manfre, Nutrition and Health Category Manager at Naturex, tells NutritionInsight. “Turmeric has become the botanical superstar [globally]. If you look at the European market, the recent growth in the last year is 30 to 40%.” 

Nutrition & Health News 24 February 2017

Curcumin – Clinical Support for Bioavailability of Wacker Product

24 Feb 2017 --- A clinical study that was recently published in the European Journal of Nutrition shows that the bioavailability of curcumin can be increased significantly with the help of gammadextrin – by a factor of 40 compared to conventional curcumin extract. 

Video Interviews

The Science Behind Cavacurmin

27 June 2017 At Vitafoods 2017, Wacker presented ...